What is included in patient education for Henoch-Schönlein purpura (IgA vasculitis)?

Updated: Jan 08, 2021
  • Author: Rajendra Bhimma, MBChB, MD, PhD, DCH (SA), FCP(Paeds)(SA), MMed(Natal); Chief Editor: Craig B Langman, MD  more...
  • Print

Patients should be informed that the disease is most likely to resolve with few residual adverse effects but that relapses are possible. The clinician should explain that severe kidney involvement is rare but that if it does occur, aggressive treatment may be required.

For patient education information, see Henoch-Schonlein Purpura.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!